Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Haydale Graphene Industries (HAYD) by Nigel Somerville in ShareProphets
- Buy Amaroq Minerals Ltd. Npv (DI) (AMRQ) by Tom Winnifrith in ShareProphets
- Buy Amaroq Minerals Ltd. Npv (DI) (AMRQ) by Steve Moore in ShareProphets
- Add Shell (SHEL) by Simon Watkins in The Motley Fool
- Watch Card Factory (CARD) by Steve Moore in ShareProphets
- Buy Frasers Group (FRAS) by Bank of America
- Buy Card Factory (CARD) by UBS
- Hold easyJet (EZJ) by Mark Hartley in The Motley Fool
- Neutral Berkeley Group Holdings (The) (BKG) by Citi
- Buy Bridgepoint Group (Reg S) (BPT) by Deutsche Bank
- Hold AIB Group (CDI) (AIBG) by Deutsche Bank
- Hold Tesco (TSCO) by Jefferies
- Underperform Associated British Foods (ABF) by Jefferies
- Hold Next (NXT) by Jefferies
- Sector Perform Marks & Spencer Group (MKS) by RBC Capital
- Sector Perform Smith & Nephew (SN.) by RBC Capital
- Outperform FirstGroup (FGP) by RBC Capital
- Outperform Mony Group (MONY) by RBC Capital
- Buy Kistos Holdings (KIST) by Berenberg
- Buy Card Factory (CARD) by Berenberg
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 18 open tips for Physiomics (PYC)
| Latest Bid : 0.27p | Latest Ask : 0.30p |
| High Today : 0.30p | Low Today : 0.27p |
| This Years High : 1.15p | This Years Low : 0.26p |
| Volume : 4,654,281 | MKT Cap : £0.57M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2025-02-13 13:45:00 13/02/2025 | 43.00% |
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | 52.50% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | 52.50% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 76.25% |
| Sell | Tom Winnifrith | Premium Only | 2024-03-07 16:20:00 07/03/2024 | 78.08% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.27p | Latest Ask : 0.30p |
| High Today : 0.30p | Low Today : 0.27p |
| This Years High : 1.15p | This Years Low : 0.26p |
| Volume : 4,654,281 | MKT Cap : £0.57M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2025-02-13 13:45:00 13/02/2025 | 43.00% |
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | 52.50% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | 52.50% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 76.25% |
| Sell | Tom Winnifrith | Premium Only | 2024-03-07 16:20:00 07/03/2024 | 78.08% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000